Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
His resignation would be effective from March 18, 2024
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Stedycon Sted super-resolution fluorescence microscope
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
Subscribe To Our Newsletter & Stay Updated
